VITALE, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 598
EU - Europa 124
AS - Asia 85
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 816
Nazione #
US - Stati Uniti d'America 598
SG - Singapore 37
RU - Federazione Russa 31
CN - Cina 25
IT - Italia 21
DE - Germania 17
UA - Ucraina 12
BE - Belgio 11
VN - Vietnam 10
IN - India 9
CZ - Repubblica Ceca 8
GB - Regno Unito 7
IE - Irlanda 7
BR - Brasile 5
AT - Austria 2
FI - Finlandia 2
IR - Iran 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
FR - Francia 1
GR - Grecia 1
LV - Lettonia 1
RO - Romania 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 816
Città #
Chandler 78
Fairfield 73
Ashburn 60
Ann Arbor 46
Seattle 33
Singapore 32
Houston 24
Cambridge 23
Woodbridge 23
Wilmington 18
Boardman 17
Princeton 12
Beijing 11
Brussels 11
Dearborn 10
Dong Ket 10
New York 9
Brno 7
Dublin 7
Jacksonville 6
Martignacco 6
Redmond 5
San Diego 5
Leawood 4
Los Angeles 4
Munich 4
Norwalk 3
Nuremberg 3
Ogden 3
Washington 3
Edinburgh 2
Frankfurt am Main 2
Helsinki 2
Newark 2
Trieste 2
Ardabil 1
Asti 1
Athens 1
Augusta 1
Bangalore 1
Baoding 1
Bento Gonçalves 1
Boston 1
Cairo 1
Campina Grande 1
Chengdu 1
Clifton 1
Dallas 1
Des Moines 1
Dubai 1
Dushanbe 1
Florence 1
Fuzhou 1
Hyderabad 1
Jinan 1
Johannesburg 1
Kunming 1
London 1
Melfi 1
Monmouth Junction 1
Mortegliano 1
Nanjing 1
Nova Friburgo 1
Paris 1
Pinhais 1
Prague 1
Quito 1
Riga 1
San Mateo 1
San Remo 1
Santa Clara 1
Shenzhen 1
São Paulo 1
Trento 1
Udine 1
Vienna 1
Wenzhou 1
Wuhan 1
Zibo 1
Totale 604
Nome #
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 117
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 110
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 107
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 98
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 91
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario 82
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 58
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 48
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 39
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 38
Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer? 34
Melanoma immunotherapy: strategies to overcome pharmacological resistance 31
Totale 853
Categoria #
all - tutte 4.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.137


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202093 0 0 0 0 0 0 0 0 39 24 21 9
2020/2021155 7 13 11 17 12 6 10 20 6 11 24 18
2021/2022118 14 11 0 0 4 0 6 6 1 13 51 12
2022/2023159 13 25 3 22 19 27 1 8 23 2 9 7
2023/202487 9 1 3 5 12 26 0 6 5 2 0 18
2024/2025136 8 14 7 17 19 13 23 15 20 0 0 0
Totale 853